Collectively, our findings revealed a novel mechanism wherein MALAT1 interacts with c-MYC to transactivate KTN1 for enhancing EGFR protein expression, which finally contributes to the development of cSCC (Fig. 6g). The gene discussed is EGFR; the disease is skin squamous cell carcinoma.